DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
Ematobase.it
Onco News

Search results for "Rinvoq"

The FDA ( U.S. Food and Drug Administration ) has approved Rinvoq ( Upadacitinib ), a 15 mg, once-daily oral Janus kinase ( JAK ) inhibitor, for the treatment of adults with moderately to severely act ...